Clinical trials sponsored by Kind Pharmaceuticals LLC

Phase breakdown

Conditions studied

Recruiting trials led by Kind Pharmaceuticals LLC

• A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
  NCT07494409 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
  NCT07487727 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
  NCT05187832 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials is Kind Pharmaceuticals LLC recruiting for?

Kind Pharmaceuticals LLC is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.